Enanta Pharmaceuticals Inc

Healthcare · Biotechnology

12.50$ +3.3% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Enanta Pharmaceuticals Inc (ENTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 297 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ENTA
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	281	278	279	276	327	341	355	379	414	454	462	473	490	511	514	512	491	481	468	450	441	441	407	385	381	348	326	495	462	428	414	399	377	349	323	301	281	330	315	297
Current Assets	232	224	191	206	238	248	306	340	380	423	424	451	402	441	403	413	437	446	428	321	319	327	342	313	312	284	271	448	423	390	351	287	300	268	243	223	204	199	178	204
Cash	17	21	19	22	66	68	67	42	64	74	106	94	51	28	74	100	87	55	77	4.6	57	99	41	28	44	42	73	95	85	40	64	36	37	84	60	45	32	37	35	33
Cash & Short-Term Investments	210	209	176	192	224	220	257	273	309	346	370	389	335	374	355	370	387	386	376	257	244	259	280	253	249	214	210	387	370	337	300	230	248	217	193	204	189	186	164	190
Receivables	13	10	9.0	7.5	11	23	44	57	67	70	40	44	51	53	28	19	23	32	20	52	61	56	47	48	49	51	18	19	40	40	40	41	39	40	41	8.4	6.9	8.5	7.8	6.5
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	0.0	–	0.0	0.0	0.0	–	–	–	–	–	0.0	0.0	0.0	–	0.0	0.0	0.0	–	–	–	–	–	–	–	–
Property, Plant & Equipment	8.0	8.3	8.5	8.1	8.0	7.9	8.6	8.4	8.4	9.5	11	11	11	10	9.7	9.3	8.6	7.8	7.0	13	11	24	4.8	28	30	8.7	11	36	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	11	10	13	15	25	23	21	18	21	27	25	25	27	29	28	31	35	29	32	33	41	56	48	47	59	47	57	257	246	237	247	250	248	237	229	222	216	203	198	196
Current Liabilities	7.9	6.4	9.2	11	21	19	17	14	16	23	20	21	23	19	20	24	24	23	27	29	36	38	31	23	30	23	32	68	63	62	55	58	58	49	46	45	49	45	46	54
Short-Term Debt	0.1	0.1	0.1	0.1	0.1	1.9	1.9	1.8	–	–	–	–	–	3.1	3.8	4.3	4.3	5.2	5.2	5.0	4.2	3.5	3.0	2.6	2.9	3.5	4.9	42	40	46	37	35	36	34	33	30	34	35	35	3.9
Accounts Payable	3.4	2.0	4.1	5.5	3.7	3.3	4.7	4.9	4.7	5.6	8.9	6.5	6.7	6.6	5.9	6.1	5.7	6.3	5.7	5.9	9.5	7.8	6.0	1.2	6.0	4.4	12	7.9	4.1	9.3	6.7	11	8.0	4.7	4.8	3.5	1.9	1.9	4.4	3.3
Long-Term Debt	0.5	0.4	0.4	0.4	0.4	0.4	1.5	1.5	1.6	1.6	1.6	1.6	1.6	1.6	1.6	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	270	268	266	261	302	318	333	361	394	427	436	448	462	482	486	481	456	452	436	418	399	384	359	338	321	301	269	238	217	192	166	149	129	112	94	79	65	127	117	101
Retained Earnings	28	23	17	8.8	45	57	70	90	117	143	148	155	164	177	171	157	128	119	97	73	49	18	-15	-47	-73	-102	-140	-179	-207	-240	-272	-294	-323	-345	-368	-386	-405	-417	-430	-449
Shares Outstanding	19	19	19	19	20	20	21	21	21	21	21	21	21	21	20	20	20	20	20	20	20	20	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	29	29	29

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings